News Image

Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss

Provided By PR Newswire

Last update: Oct 18, 2022

Proposed acquisition will accelerate gene therapies that aim to restore, improve, and preserve hearing for patients living with disabling hearing loss worldwide

Read more at prnewswire.com

ELI LILLY & CO

NYSE:LLY (7/22/2025, 8:27:15 PM)

After market: 776.75 +0.31 (+0.04%)

776.44

+14.26 (+1.87%)



Find more stocks in the Stock Screener

LLY Latest News and Analysis

5 days ago - By: Chartmill - Mentions: ALB PEP BX PLD ...
Follow ChartMill for more